A patient is taking fluconazole 200 mg once weekly for onychomycosis and now has a yeast infection; how should the yeast infection be treated while continuing the fluconazole regimen?

Treatment Recommendation

For a patient on fluconazole 200 mg weekly for toenail onychomycosis who develops a vaginal yeast infection, treat the vaginal infection with a single dose of fluconazole 150 mg orally and continue the weekly 200 mg regimen for the onychomycosis. 1

Rationale

The FDA-approved dosing for uncomplicated vaginal candidiasis is a single 150 mg oral dose of fluconazole 1. This is a distinct, one-time treatment that does not interfere with the ongoing weekly 200 mg maintenance regimen for onychomycosis.

Key Clinical Points

Dosing Strategy:

• Give fluconazole 150 mg as a single dose for the vaginal yeast infection
• Continue the weekly 200 mg dose for onychomycosis on its regular schedule
• These regimens do not conflict—the single 150 mg dose addresses the acute vaginal infection while the weekly 200 mg continues to suppress the nail fungus

Why This Approach Works:

• The patient is already tolerating systemic fluconazole without issues
• A single 150 mg dose provides adequate treatment for uncomplicated vulvovaginal candidiasis with high efficacy 2, 1
• The weekly 200 mg dose for onychomycosis is insufficient for treating active vaginal candidiasis, which requires either a single higher dose or daily dosing 1

Alternative Considerations

If topical therapy is preferred:

• Topical azole antifungals (clotrimazole, miconazole) can be used for uncomplicated vaginal yeast infections 2
• This avoids any theoretical concern about overlapping systemic antifungal exposure
• However, oral fluconazole 150 mg single dose remains the most convenient and equally effective option

Important Caveats:

• Confirm this is truly uncomplicated vulvovaginal candidiasis (typical symptoms: itching, discharge, no systemic signs)
• If symptoms persist after treatment or recur frequently (≥4 episodes/year), consider recurrent vulvovaginal candidiasis requiring longer maintenance therapy 2, 3
• The development of a yeast infection while on systemic fluconazole is unusual but can occur with local vaginal factors or non-albicans Candida species
• If the infection fails to respond, obtain culture to identify the Candida species and assess for azole resistance 2